Anti-Human EPCAM Therapeutic Antibody (Adecatumumab)

Recombinant monoclonal antibody to EpCAM. which is used to target tumor cells. It binds to the epithelial cell adhesion molecule (EpCAM - CD326). Adecatumumab has been used in clinical studies of treatment in prostate and breast cancers.
Supplier Creative Biolabs
Product # TAB-106
Pricing Inquiry
Host Human
Target EpCAM
Species Reactivity Human
Type IgG1
Applications FC, IHC, FuncS, Inhib, Cyt
Storage Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage.
Feedback